retatrutide clinical trials obesity New GLP-1 drug, retatrutide, shows added benefits TRIUMPH-3 🇦🇺 retatrutide cardiovascular/obesity clinical

Forest plot depicting the meta-analysis of odds ratios (ORs) for inadequate bowel preparation in glucagon-like peptide-1 receptor agonists users vs

Laila Gohar (artist): Everyone in L.A

Activated PKA promotes the PI3K/mTOR pathway in -cells, leading to the activation of the Hypoxia-Inducible Factor 1 (HIF-1)

If I have surgery early ( Stage 1 or 2) will this slow the progression of disease

In April 2025 Pfizer was forced to discontinue a clinical trial with one of its experimental GLP-1 medicines to treat obesity due to potential drug induced liver injury found in one of the participants

Hims launches a $39 GLP1 weight loss membership for men What is Hims